“【Re

This seminar focuses on the complexities of M&A and business succession within the unique legal structure of medical corporations, and the differences compared to business companies. Unlike for-profit business companies, medical corporations have unique succession schemes due to restrictions on the transfer of equity interests. Legal procedures such as approval by the general meeting of members, resolution by the board of directors, and notification to the regional bureau are also complex. This seminar is highly beneficial for executives and successors of medical institutions as it clarifies the specific challenges of medical corporations and the points to note in M&A with business companies.

In the context of medical M&A and business succession, understanding this "uniqueness" is key to achieving a smooth transaction. The transferring party needs to find an acquirer who can maintain and develop their institution's corporate status and medical care system, while the acquiring party needs a strategy to improve management and expand business while complying with medical corporation regulations. Flexible consideration tailored to individual circumstances is essential, such as utilizing schemes like "loans to medical corporations" or "refunds of funds" as alternatives to equity interests, or transferring "member" qualifications of the medical corporation.

For executives of medical institutions and those facing succession issues, the "early consultation with experts" is highlighted as important. M&A of medical corporations requires more specialized knowledge and experience than general business succession. Understanding the unique issues of special corporations, as explained in this seminar, and accurately assessing your institution's situation, makes early collaboration with M&A support organizations, tax accountants, and other experts the fastest path to success. Even when considering closure, we hope you recognize that business succession can be an option to contribute to regional healthcare.